We are closer than ever to developing an urgently needed hepatitis C vaccine. But in order to get there we need your help.
Antibodies are key effector molecules responsible for mediating protection against many other infectious diseases.
This project will involve engineering novel recombinant antibodies against malaria parasite proteins and those of other infectious diseases organisms.
These will then be used in a range of in vitro immunological assays to determine their precise functional mechanisms and efficacy in protective immunity.